QUOTIENT LIMITED 12,000,000 Ordinary Shares (no par value per Share) UNDERWRITING AGREEMENT November 6, 2019Underwriting Agreement • November 12th, 2019 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
Each of the undersigned, Franz Walt, Chief Executive Officer of Quotient Limited, a company organized under the laws of Jersey (the “Company”), and Christopher Lindop, Chief Financial Officer of the Company, on behalf of the Company, does hereby certify pursuant to Section 6(k) of that certain Underwriting Agreement dated [•], 2019 (the “Underwriting Agreement”) among the Company and the Underwriters named therein, that as of [•], 2019:
